Chemitope Glycopeptide Inc.

Biotechnology company · Brooklyn, New York, United States

Chemitope Glycopeptide Inc. is a biotechnology company headquartered in Brooklyn, New York, United States. Its earliest recorded incorporation is in 2016. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $599,591 in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $200,000 sold in a notice filed in 2019.

www.chemitopeglycopeptide.comProfile compiled from public records. Is this your company? Request a correction or update

Chemitope Glycopeptide at a glance

Typebiotechnology company
HeadquartersBrooklyn, New York, United States
Earliest incorporation on record2016
Employees (self-reported, 2019)2
SEC CIK1714830

What does Chemitope Glycopeptide do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $599,591 in total (2019). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $200,000 sold (2019).

Frequently asked questions about Chemitope Glycopeptide

Where is Chemitope Glycopeptide headquartered?

Chemitope Glycopeptide Inc. is headquartered in Brooklyn, New York, United States.

What does Chemitope Glycopeptide do?

Chemitope Glycopeptide Inc. is a biotechnology company.

When was Chemitope Glycopeptide founded?

The earliest incorporation on record for Chemitope Glycopeptide Inc. is in 2016, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences